Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ViOptix

ViOptix?uq=kzBhZRuG
1999 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Debt LATEST DEAL TYPE
$170K LATEST DEAL AMOUNT
11 INVESTORS
Description

Developer of medical devices designed to measure oxygen saturation levels in tissues. The company's medical devices measure tissue oxygen saturation post-operatively in real time during pre-op baseline assessment, intra-operative mapping and post-op ICU monitoring, enabling patient to have improved surgical outcomes.

Website
Formerly Known As
Photonify Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Primary Office
  • 39655 Eureka Drive
  • Newark, CA 94560
  • United States

+1 (510) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ViOptix’s full profile, request a free trial.

ViOptix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Debt - General 31-Mar-2012 $170K 000.00 Completed Generating Revenue
10. Later Stage VC (Series E) 14-Feb-2011 000 000.00 Completed Generating Revenue
9. Debt - General 31-Dec-2010 00000 000.00 Completed Generating Revenue
8. Later Stage VC (Series C) 12-Sep-2009 00.00 000.00 000.00 Completed Startup
7. Later Stage VC 22-May-2009 00.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 09-Dec-2008 000.00 000.00 Completed Generating Revenue
5. Later Stage VC 31-Mar-2008 00000 0000 Completed Generating Revenue
4. Later Stage VC (Series D) 07-Jan-2008 00.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 27-Jul-2004 $5.14M $11.1M Completed Startup
2. Early Stage VC 20-Nov-2003 $1.73M $6M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ViOptix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series X 0 00.000000 00 00 00 00 00
Series B 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A2 2,000,002 $0.001000 $1 $1 1x $0.78 4.09%
Series A1 2,642,870 $0.001000 $0.35 $0.35 1x $0.35 4.22%
To view this company’s complete Cap Table, request access »

ViOptix Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
DowsLake Venture Venture Capital Minority 000 0000 000000 0
Lumira Ventures Venture Capital Minority 000 0000 000000 0
Trident Capital Venture Capital Minority 000 0000 000000 0
Vivo Capital Venture Capital Minority 000 0000 000000 0
Horizon Technology Finance Lender/Debt Provider Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

ViOptix Executive Team (4)

Name Title Board
Seat
Contact
Info
Scott Coleridge Chief Executive Officer, President & Board Member
Mark Lonsinger Vice President & General Manager
Melissa Liu Controller
L. John Lloyd Executive Chairman & Board Member

ViOptix Board Members (5)

Name Representing Role Since Contact
Info
Donna Parr Self Board Member 000 0000
Joseph Reagan Self Board Member 000 0000
L. John Lloyd ViOptix Executive Chairman & Board Member 000 0000
Scott Coleridge ViOptix Chief Executive Officer, President & Board Member 000 0000
W.Gregory Shearer Channel Medical Partners Board Member 000 0000